MOG-AD is a neuroimmune disorder that causes inflammation primarily in the optic nerve but can also affect the spinal cord and brain. MOG is a protein located on the surface of myelin sheaths in the central nervous system. MOG-AD is diagnosed through a test that looks for the level of MOG antibodies in the blood. The test should be given to any patient who has an inflammatory attack of the central nervous system. Because of the rare nature of the disorder, it is often misdiagnosed or not diagnosed at all.
For more information, please visit www.mogproject.org
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 19, 2021 | Charity Auction Aims to Put MOG Antibody Disease Over a Barrel | OLNEY, Md. (PRWEB) November 19, 2021 The MOG Project announced today it has raised more than $51,000 to raise awareness of MOG-AD, a rare neuroinflammatory autoimmune disease found in people of all ages and children in particular. On a plat... |
| Jun 21, 2021 | The MOG Project Formally Launches as 501(c)3 to Raise Profile of Often Misidentified Neuroinflammatory Disease, MOG-AD | OLNEY, Md. (PRWEB) June 21, 2021 The MOG Project, a nonprofit organization committed to supporting the research and treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease, or MOG-AD, has commenced its national mission to raise aw... |
Reviews 0
FAQ about The MOG Project
What has the press written about The MOG Project?
Parsers VC has collected 3 articles mentioning The MOG Project, among them “Charity Auction Aims to Put MOG Antibody Disease Over a Barrel” (Nov 19, 2021) and “The MOG Project Formally Launches as 501(c)3 to Raise Profile of Often Misidentified Neuroinflammatory Disease, MOG-AD” (Jun 21, 2021).
Is The MOG Project still active?
Yes, The MOG Project is active; its latest activity on Parsers VC dates from Feb 25, 2022.